Complementary Neurosteroid Intervention in Gulf War Illnesses (GWVI)
Status:
Completed
Trial end date:
2018-10-10
Target enrollment:
Participant gender:
Summary
This study will investigate the use of adjunctive pregnenolone for the following:
1. fatigue that has limited usual activity,
2. musculoskeletal pain involving 2 or more regions of the body and,
3. cognitive symptoms (memory, concentration, or attentional difficulties by self-report)
in Veterans deployed to the Gulf War theatre of operations between 1990 and 1991.